Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-17-035406

Options or other derivatives

  • VP, General Counsel & Corp Sec acquired 62,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Barnes Alane P · VP, General Counsel & Corp Sec

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-12-20 Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) +62,500 $5.04 2027-12-20 62,500 62,500 D
Loading xslF345X03/form4.xml…